Pharmaceutically active secondary metabolites of microorganisms.
about
Genome sequence of an industrial microorganism Streptomyces avermitilis: deducing the ability of producing secondary metabolitesStructural and enzymatic analysis of MshA from Corynebacterium glutamicum: substrate-assisted catalysisSecondary chemicals protect mould from fungivoryFermentation Conditions that Affect Clavulanic Acid Production in Streptomyces clavuligerus: A Systematic ReviewProteomic and Metabolomic Analyses Reveal Contrasting Anti-Inflammatory Effects of an Extract of Mucor Racemosus Secondary Metabolites Compared to DexamethasoneDevelopment of antibiotics and the future of marine microorganisms to stem the tide of antibiotic resistanceDiversifying carotenoid biosynthetic pathways by directed evolution.Ribonuclease P RNA gene sequencing as a tool for molecular dereplication of myxobacterial strain collections.Visualizing the spatial distribution of secondary metabolites produced by marine cyanobacteria and sponges via MALDI-TOF imaging.Screening a mushroom extract library for activity against Acinetobacter baumannii and Burkholderia cepacia and the identification of a compound with anti-Burkholderia activity.Reverse biological engineering of hrdB to enhance the production of avermectins in an industrial strain of Streptomyces avermitilisChromosomal instability in Streptomyces avermitilis: major deletion in the central region and stable circularized chromosomeWblAch, a pivotal activator of natamycin biosynthesis and morphological differentiation in Streptomyces chattanoogensis L10, is positively regulated by AdpAch.Diversity and antibacterial activity of bacteria cultured from Mediterranean Axinella spp. sponges.Possibility of bacterial recruitment of plant genes associated with the biosynthesis of secondary metabolites.Drugs and drug intermediates from fungi: Striving for greener processes.Microbial diversity and their roles in the vinegar fermentation process.Metabolomic and Transcriptomic Comparison of Solid-State and Submerged Fermentation of Penicillium expansum KACC 40815An Active Type I-E CRISPR-Cas System Identified in Streptomyces avermitilis.Variation in Pseudonocardia antibiotic defence helps govern parasite-induced morbidity in Acromyrmex leaf-cutting ants.Molecular characterization of forest soil based Paenibacillus elgii and optimization of various culture conditions for its improved antimicrobial activity.Solid-state fermentation systems-an overview.Diversity, Phylogeny, anticancer and antimicrobial potential of fungal endophytes associated with Monarda citriodora L.Inhibition of biofouling by marine microorganisms and their metabolites.Optimization of Antioxidant Potential of Penicillium granulatum Bainier by Statistical Approaches.Free radical scavenging and antimicrobial properties of extracts of wild mushrooms.Broad-spectrum antimicrobial epiphytic and endophytic fungi from marine organisms: isolation, bioassay and taxonomyCharacterization of a Biflaviolin Synthase CYP158A3 from Streptomyces avermitilis and Its Role in the Biosynthesis of Secondary Metabolites.Production of microbial secondary metabolites: regulation by the carbon source.Carbon source regulation of antibiotic production.Triggers and cues that activate antibiotic production by actinomycetes.Characterization of the biochemical, physiological, and medicinal properties of Streptomyces hygroscopicus ACTMS-9H isolated from the Amazon (Brazil).Actinobacteria and Myxobacteria-Two of the Most Important Bacterial Resources for Novel Antibiotics.New antifungal compounds from Aspergillus terreus isolated from desert soil.Detection of proteases from Sporosarcina aquimarina and Algoriphagus antarcticus isolated from Antarctic soil.Use of direct-infusion electrospray mass spectrometry to guide empirical development of improved conditions for expression of secondary metabolites from actinomycetes.Co-occurrence of toxic bacterial and fungal secondary metabolites in moisture-damaged indoor environments.Differentiation of Micromonospora isolates from a coastal sediment in Wales on the basis of Fourier transform infrared spectroscopy, 16S rRNA sequence analysis, and the amplified fragment length polymorphism technique.Binding and molecular dynamic studies of sesquiterpenes (2R-acetoxymethyl-1,3,3-trimethyl-4t-(3-methyl-2-buten-1-yl)-1t-cyclohexanol) derived from marine Streptomyces sp. VITJS8 as potential anticancer agent.A novel redox mechanism for the glutathione-dependent reversible uptake of a fungal toxin in cells.
P2860
Q22066227-50DF0BD6-BF03-4352-8890-4129DC5E9494Q24643959-0407B792-96CD-4177-8997-2CC9697AF53EQ24652255-1CA42E70-80EE-473B-8668-820D27A1E3E6Q26752581-EABB8DCA-7980-4FF0-B70A-E9A06B704CC8Q28550466-DA2F0D3D-3E04-4DE0-A3C2-BB555C1E998EQ28828265-DFE96FD0-D68E-48BA-8FA8-37D5F5C3C1EDQ31152254-A26B8062-D61D-4166-ADE5-71FB1F662593Q33304387-2F156772-C532-4F8C-9A36-9180D9A498B8Q33336616-F71E05F0-869C-4146-ABB3-C250595700AAQ33525706-A2E61042-F36E-4933-A281-38249BCCF5ADQ33599539-9AD65555-FAD9-4F52-8259-DA379080AFB2Q33639051-A5B0F6A1-C11E-41DE-8955-981C0FFA96EAQ34594178-AC4F46A5-CCBC-460B-84B6-B29941EF908CQ35051542-349ACDB0-5B30-4C2B-8204-BECB29359A38Q35176288-FD99B50B-8280-4E46-89D8-5F0681E0B611Q35232348-BBF272B6-0C27-4466-9400-D8F98D0FA318Q35630886-14C28DAC-DC7F-48C0-9702-E4A2713DCCE9Q35919728-C2B0C8BB-6E8F-4E9C-ABD1-D58ECB7B5AA8Q35931297-124F3540-D5D3-4551-8CBE-90154059089AQ36161734-AEFC94F8-1F04-4CFC-A32D-0826678C769CQ36182426-C7450D7D-0972-4DB6-A230-8F68D7C214B5Q36184641-C5B453DE-BB95-43AC-8ADE-886970F7FFF9Q36298706-5DB1D41A-C53C-474D-9046-FDB93EEDBC14Q36427624-EE720779-6DBD-4D1B-B3F4-2D1BD935DD2FQ36857858-B64C1DCC-DF75-4E8F-B82D-610929F3E645Q37162054-9100B511-414C-46F1-93D1-47AF3473B68FQ37253565-1CA20157-8AFF-4C95-A525-1931DBBC1131Q37685097-0F3F7231-514D-4550-8129-5D067CA2C608Q37704410-8059382E-C815-4FB7-842B-7442ED81160CQ37776153-F4688CCC-6A71-429C-8507-CF8FECC47941Q38125903-8767F570-B0F3-43D2-827E-1C71F0F1D4BAQ38739752-E08EC1A7-7CD1-40D9-A7EE-80165E18D85CQ38814785-5DFB7840-2F2B-4FA1-9D1D-5B021B661A3FQ38884496-E8C8B707-68F5-44EC-A450-92B75D87599CQ39025536-C5206D4C-326A-48CA-A10E-A6EE8E00EB40Q39489384-671D8404-DAD5-4F3F-A402-28BECC72D9ECQ39749419-C012021D-772B-4FC7-985D-485B9E14AEFAQ40279341-479AE4D3-D292-49E1-B90F-3EF556DC79FCQ40293724-209BDBBD-A548-4417-979C-D93457D954CAQ40639199-8FBD81AA-6D8E-405F-AC2C-24E8F5EFC5D6
P2860
Pharmaceutically active secondary metabolites of microorganisms.
description
1999 nî lūn-bûn
@nan
1999 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Pharmaceutically active secondary metabolites of microorganisms.
@ast
Pharmaceutically active secondary metabolites of microorganisms.
@en
type
label
Pharmaceutically active secondary metabolites of microorganisms.
@ast
Pharmaceutically active secondary metabolites of microorganisms.
@en
prefLabel
Pharmaceutically active secondary metabolites of microorganisms.
@ast
Pharmaceutically active secondary metabolites of microorganisms.
@en
P356
P1476
Pharmaceutically active secondary metabolites of microorganisms.
@en
P2093
P2888
P304
P356
10.1007/S002530051546
P407
P577
1999-10-01T00:00:00Z
P5875
P6179
1053458320